跳至主要内容
临床试验/CTRI/2025/10/096546
CTRI/2025/10/096546尚未招募不适用

Clinical Validation Of Cure Catalyst -AI Diagnostic And Predictive Tool

Superceuticals Private Ltd1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2025年12月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
1,000
试验地点
1
主要终点
Diagnostic accuracy Sensitivity Specificity Predictive value of cure catalyst AI compared to dermatological assessment

研究概览

简要总结

This clinical study aims to validate the performance of Cure Catalyst ,an AI -powered diagnostic and predictive tool for dermatological conditions .The tool leverages machine learning algorithm to analyze skin images and patient data for accurate and early detection of common dermatological disorders .

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients presenting the visible dermatological conditions e.g rashes lesions pigmentation disorders inflammatory and non inflammatory diseases.

排除标准

  • 未提供

结局指标

主要结局

Diagnostic accuracy Sensitivity Specificity Predictive value of cure catalyst AI compared to dermatological assessment

时间窗: At baseline

次要结局

未报告次要终点

研究者

发起方
Superceuticals Private Ltd
申办方类型
Other [Company owned]
责任方
Principal Investigator
主要研究者

DRBhavana Doshi

KLES Dr.Prabhakar Kore Hospital

研究点 (1)

Loading locations...

相似试验